• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻及其可允许状况。

Cannabis and Its Permissibility Status.

机构信息

Department of Applied Chemistry, College of Applied Sciences, Palestine Polytechnic University, Hebron, Palestine.

Department of Chemistry, University of Zurich, Zurich, Switzerland.

出版信息

Cannabis Cannabinoid Res. 2021 Dec;6(6):451-456. doi: 10.1089/can.2020.0017. Epub 2020 May 12.

DOI:10.1089/can.2020.0017
PMID:33998850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8713275/
Abstract

Cannabis has been used and misused to treat many disorders. Δ-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most important components of cannabis and could be used for recreational and medical purposes. The permissibility (Halal) status of cannabis is controversial, and its rational use is ambiguous. Global awareness and interest in cannabis use are increasing and its permissibility status, especially for recreational and medical purposes, needs to be addressed. Rationalizing the scientific value and Halal status of cannabis is useful for the rational use and maintenance of the compatible system. It is rare in Muslim countries to discuss the permissibility status of cannabis from the perspective of its value and composition. Using the analogy concept, the CBD component extracted from a cannabis plant in a clean and pure form is permissible to use in industry, particularly in cosmetics and pharmaceuticals. If THC component is present in <1% and CBD is >99%, the mixture is considered permissible as long as THC is not intentionally added or intentionally left, but is mainly present due to the limited capabilities and efficiency of the purification methods. However, any amount of THC prepared with the intention to be used as an intoxicant is considered non-Halal.

摘要

大麻已被用于治疗多种疾病,但也被误用。Δ-四氢大麻酚(THC)和大麻二酚(CBD)是大麻中最重要的成分,可用于娱乐和医疗目的。大麻的可接受性(清真)地位存在争议,其合理使用也存在歧义。全球对大麻使用的认识和兴趣正在增加,需要解决其可接受性地位,特别是娱乐和医疗目的。使大麻的科学价值和清真地位合理化,有助于合理使用和维护兼容系统。在穆斯林国家,很少从其价值和成分的角度讨论大麻的可接受性地位。使用类比概念,从大麻植物中以清洁和纯净形式提取的 CBD 成分可用于工业,特别是在化妆品和制药领域。如果 THC 成分含量<1%,而 CBD 含量>99%,则只要 THC 不是故意添加或故意留下,而是由于净化方法的能力和效率有限而主要存在,混合物就被认为是可接受的。但是,任何意图用作麻醉剂的 THC 制备都被认为是不可清真的。

相似文献

1
Cannabis and Its Permissibility Status.大麻及其可允许状况。
Cannabis Cannabinoid Res. 2021 Dec;6(6):451-456. doi: 10.1089/can.2020.0017. Epub 2020 May 12.
2
Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.Δ⁹-四氢大麻酚(THC)、大麻二酚(CBD)及其混合物对恒河猴选择芬太尼与食物的影响。
Drug Alcohol Depend. 2023 Mar 1;244:109787. doi: 10.1016/j.drugalcdep.2023.109787. Epub 2023 Feb 1.
3
Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.美国和加拿大大麻消费者中四氢大麻酚和大麻二酚水平的相关知识。
Cannabis Cannabinoid Res. 2022 Jun;7(3):345-354. doi: 10.1089/can.2020.0092. Epub 2020 Oct 29.
4
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.含有等效浓度的 delta-9-四氢大麻酚 (THC) 和大麻二酚 (CBD) 的大麻引起的状态焦虑少于 THC 占主导的大麻。
Psychopharmacology (Berl). 2022 Nov;239(11):3731-3741. doi: 10.1007/s00213-022-06248-9. Epub 2022 Oct 13.
5
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.THC 和 CBD:反派与英雄?青少年接触的深入洞察。
Int J Mol Sci. 2023 Mar 9;24(6):5251. doi: 10.3390/ijms24065251.
6
Public interest in ∆-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆-Tetrahydrocannabinol (delta-9-THC) use.公众对∆-四氢大麻酚(δ-8-THC)的兴趣在美国各州限制∆-四氢大麻酚(δ-9-THC)使用后有所增加。
Int J Drug Policy. 2022 Mar;101:103557. doi: 10.1016/j.drugpo.2021.103557. Epub 2021 Dec 21.
7
What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio.你对玛丽珍(大麻的俗称)了解多少?对 THC:CBD 比值现有数据的系统综述。
Subst Use Misuse. 2020;55(8):1223-1227. doi: 10.1080/10826084.2020.1731547. Epub 2020 Mar 3.
8
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.大麻中 Δ9-四氢大麻酚(THC)和大麻二酚(CBD)浓度随时间的变化:系统评价和荟萃分析。
Addiction. 2021 May;116(5):1000-1010. doi: 10.1111/add.15253. Epub 2020 Nov 7.
9
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ-Tetrahydrocannabinol.临床前和临床证据表明大麻二酚和Δ-四氢大麻酚的功能相互作用。
Neuropsychopharmacology. 2018 Jan;43(1):142-154. doi: 10.1038/npp.2017.209. Epub 2017 Sep 6.
10
Δ-Tetrahydrocannabinol Differentially Alters Cannabidiol Efficacy in Recovery of Phonology and Syntax Following Damage to a Songbird Cortical-Like Brain Region.Δ-四氢大麻酚对鸣禽皮质样脑区损伤后语音和句法恢复中大麻素疗效的差异影响。
Cannabis Cannabinoid Res. 2023 Oct;8(5):790-801. doi: 10.1089/can.2022.0073. Epub 2022 Sep 19.

引用本文的文献

1
Effects of Cannabidiol on Locomotor Activity.大麻二酚对运动活性的影响。
Life (Basel). 2022 Apr 27;12(5):652. doi: 10.3390/life12050652.

本文引用的文献

1
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.与大麻二酚 (CBD) 的药物相互作用似乎不会对开放标签扩大准入计划中的治疗反应产生影响。
Epilepsy Behav. 2019 Sep;98(Pt A):201-206. doi: 10.1016/j.yebeh.2019.07.008. Epub 2019 Aug 2.
2
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.使用医用和消费级大麻二酚(CBD)时潜在的药物不良事件和药物相互作用。
J Clin Med. 2019 Jul 8;8(7):989. doi: 10.3390/jcm8070989.
3
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.天然产物提取物中的协同作用和拮抗作用:当 1 + 1 不等于 2 时。
Nat Prod Rep. 2019 Jun 19;36(6):869-888. doi: 10.1039/c9np00011a.
4
CBD: A New Hope?大麻二酚:新的希望?
ACS Med Chem Lett. 2019 Apr 29;10(5):694-695. doi: 10.1021/acsmedchemlett.9b00127. eCollection 2019 May 9.
5
Halalopathy: A science of trust in medicine.清真医学:医学信任的科学。
J Integr Med. 2019 May;17(3):150-154. doi: 10.1016/j.joim.2019.03.005. Epub 2019 Mar 23.
6
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.大麻二酚:神经精神疾病治疗的最新进展和新见解。
Life Sci. 2019 May 1;224:120-127. doi: 10.1016/j.lfs.2019.03.053. Epub 2019 Mar 22.
7
CBD as the New Medicine in the Pain Provider's Armamentarium.大麻二酚作为疼痛治疗手段中的新型药物。
Pain Ther. 2019 Jun;8(1):157-158. doi: 10.1007/s40122-019-0117-1. Epub 2019 Mar 12.
8
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.人类研究综述评估大麻二酚(CBD)的治疗作用和潜力。
J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7.
9
Response of Plant Secondary Metabolites to Environmental Factors.植物次生代谢物对环境因子的响应。
Molecules. 2018 Mar 27;23(4):762. doi: 10.3390/molecules23040762.
10
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD.建立一种简单且灵敏的液相色谱-三重四极杆质谱法(LC-MS/MS),用于测定单次高剂量口服大麻二酚(CBD)后大鼠全血中大麻二酚(CBD)、Δ-四氢大麻酚(THC)及其代谢物的含量。
J Pharm Biomed Anal. 2018 Feb 20;150:25-32. doi: 10.1016/j.jpba.2017.11.054. Epub 2017 Nov 28.